Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 573

1.

Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.

Sailer V, Eng KW, Zhang T, Bareja R, Pisapia DJ, Sigaras A, Bhinder B, Romanel A, Wilkes D, Sticca E, Cyrta J, Rao R, Sahota S, Pauli C, Beg S, Motanagh S, Kossai M, Fontunge J, Puca L, Rennert H, Zhaoying Xiang J, Greco N, Kim R, MacDonald TY, McNary T, Blattner-Johnson M, Schiffman MH, Faltas BM, Greenfield JP, Rickman D, Andreopoulou E, Holcomb K, Vahdat LT, Scherr DS, van Besien K, Barbieri CE, Robinson BD, Fine HA, Ocean AJ, Molina A, Shah MA, Nanus DM, Pan Q, Demichelis F, Tagawa ST, Song W, Mosquera JM, Sboner A, Rubin MA, Elemento O, Beltran H.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.19.00047. Epub 2019 Sep 20.

PMID:
31592503
2.

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes.

Wagner S, Roberson D, Boland J, Kreimer AR, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Porras C, Cortes B, Sampson J, Herrero R, Rodriguez AC, Quint W, Van Doorn LJ; CVT Group , Hildesheim A, Schiffman M, Wentzensen N.

J Infect Dis. 2019 Oct 8;220(10):1609-1619. doi: 10.1093/infdis/jiz324.

PMID:
31536132
3.

Experiences and psychological outcomes of the oocyte donor: a survey of donors post-donation from one center.

Blakemore JK, Voigt P, Schiffman MR, Lee S, Besser AG, Fino ME.

J Assist Reprod Genet. 2019 Jul 13. doi: 10.1007/s10815-019-01527-5. [Epub ahead of print]

PMID:
31300913
4.

Viral coinfection analysis using a MinHash toolkit.

Dawson ET, Wagner S, Roberson D, Yeager M, Boland J, Garrison E, Chanock S, Schiffman M, Raine-Bennett T, Lorey T, Castle PE, Mirabello L, Durbin R.

BMC Bioinformatics. 2019 Jul 12;20(1):389. doi: 10.1186/s12859-019-2918-y.

5.

Inferior Mesenteric Arterial Supply to a Symptomatic Uterine Myoma.

Cornman-Homonoff J, Holcomb K, Schiffman MH.

J Minim Invasive Gynecol. 2019 Jul 9. pii: S1553-4650(19)30303-6. doi: 10.1016/j.jmig.2019.07.003. [Epub ahead of print] No abstract available.

PMID:
31299359
6.

Percutaneous drainage of an infected endometrioma.

Cornman-Homonoff J, Fenster TB, Schiffman MH.

Clin Imaging. 2019 Jun 22;58:105-107. doi: 10.1016/j.clinimag.2019.06.012. [Epub ahead of print]

PMID:
31284177
7.

Response to Pretorius and Belinson.

Schiffman M, Hu L, Antani S, Wentzensen N.

J Natl Cancer Inst. 2019 Jun 11. pii: djz119. doi: 10.1093/jnci/djz119. [Epub ahead of print] No abstract available.

PMID:
31187134
8.

Management of Recurrent Sigmoid Volvulus via Nontransmural Percutaneous Colon Fixation.

Cornman-Homonoff J, Milsom JW, Schiffman MH.

J Vasc Interv Radiol. 2019 Oct;30(10):1669-1671. doi: 10.1016/j.jvir.2019.01.028. Epub 2019 May 17. No abstract available.

PMID:
31109854
9.

Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.

Xi LF, Schiffman M, Hughes JP, Galloway DA, Koutsky LA, Kiviat NB.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1388-1394. doi: 10.1158/1055-9965.EPI-18-0802. Epub 2019 May 17.

PMID:
31101617
10.

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program.

Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS.

JAMA Intern Med. 2019 Jul 1;179(7):881-888. doi: 10.1001/jamainternmed.2019.0306. Erratum in: JAMA Intern Med. 2019 Jul 1;179(7):1007.

11.

False positive cervical HPV screening test results.

Schiffman M, de Sanjose S.

Papillomavirus Res. 2019 Jun;7:184-187. doi: 10.1016/j.pvr.2019.04.012. Epub 2019 Apr 25.

12.

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.

Landy R, Schiffman M, Sasieni PD, Cheung LC, Katki HA, Rydzak G, Wentzensen N, Poitras NE, Lorey T, Kinney WK, Castle PE.

Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32268. [Epub ahead of print]

PMID:
30861114
13.

Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing.

Wagner S, Roberson D, Boland J, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Schiffman M, Wentzensen N.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01794-18. doi: 10.1128/JCM.01794-18. Print 2019 May.

PMID:
30814267
14.

Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.

Clifford GM, Tenet V, Georges D, Alemany L, Pavón MA, Chen Z, Yeager M, Cullen M, Boland JF, Bass S, Steinberg M, Raine-Bennett T, Lorey T, Wentzensen N, Walker J, Zuna R, Schiffman M, Mirabello L.

Papillomavirus Res. 2019 Jun;7:67-74. doi: 10.1016/j.pvr.2019.02.001. Epub 2019 Feb 6.

15.

An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening.

Hu L, Bell D, Antani S, Xue Z, Yu K, Horning MP, Gachuhi N, Wilson B, Jaiswal MS, Befano B, Long LR, Herrero R, Einstein MH, Burk RD, Demarco M, Gage JC, Rodriguez AC, Wentzensen N, Schiffman M.

J Natl Cancer Inst. 2019 Sep 1;111(9):923-932. doi: 10.1093/jnci/djy225.

PMID:
30629194
16.

Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.

Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Poitras NE, Lorey TS, Katki HA, Wentzensen N, Schiffman M.

J Natl Cancer Inst. 2018 Dec 21. doi: 10.1093/jnci/djy192. [Epub ahead of print]

PMID:
30576462
17.

Percutaneous Orthotopic IVC Construction in a Pediatric Patient with Symptomatic IVC Agenesis.

Schiffman MH, Cornman-Homonoff J, Sos TA.

Cardiovasc Intervent Radiol. 2019 Feb;42(2):308-312. doi: 10.1007/s00270-018-2098-6. Epub 2018 Nov 12.

PMID:
30420997
18.

Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans.

Chen Z, DeSalle R, Schiffman M, Herrero R, Wood CE, Ruiz JC, Clifford GM, Chan PKS, Burk RD.

PLoS Pathog. 2018 Nov 1;14(11):e1007352. doi: 10.1371/journal.ppat.1007352. eCollection 2018 Nov.

19.

Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis.

Conrad RD, Liu AH, Wentzensen N, Zhang RR, Dunn ST, Wang SS, Schiffman M, Gold MA, Walker JL, Zuna RE.

Cancer Cytopathol. 2018 Nov;126(11):950-958. doi: 10.1002/cncy.22055. Epub 2018 Oct 23.

20.

Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.

Clarke MA, Cheung LC, Castle PE, Schiffman M, Tokugawa D, Poitras N, Lorey T, Kinney W, Wentzensen N.

JAMA Oncol. 2019 Feb 1;5(2):181-186. doi: 10.1001/jamaoncol.2018.4270.

21.

Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results.

Castle PE, Xie X, Xue X, Poitras NE, Lorey TS, Kinney WK, Wentzensen N, Strickler HD, Burger EA, Schiffman M.

Prev Med. 2019 Jan;118:44-50. doi: 10.1016/j.ypmed.2018.10.001. Epub 2018 Oct 11.

PMID:
30316878
22.

The next generation of cervical cancer screening programs: Making the case for risk-based guidelines.

Perkins RB, Schiffman M, Guido RS.

Curr Probl Cancer. 2018 Sep;42(5):521-526. doi: 10.1016/j.currproblcancer.2018.06.007. Epub 2018 Jun 25. No abstract available.

PMID:
30146347
23.

Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections.

Schiffman M, Huh WK, Stockdale CK, Einstein MH, Chelmow D, Flowers LC.

Obstet Gynecol. 2018 Sep;132(3):778-779. doi: 10.1097/AOG.0000000000002828. No abstract available.

24.

Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis.

Silver MI, Andrews J, Cooper CK, Gage JC, Gold MA, Khan MJ, Massad LS, Parvu V, Perkins RB, Schiffman M, Smith KM, Wentzensen N.

Obstet Gynecol. 2018 Sep;132(3):725-735. doi: 10.1097/AOG.0000000000002812.

25.

How confident can we be in the current guidelines for exiting cervical screening?

Gravitt PE, Landy R, Schiffman M.

Prev Med. 2018 Sep;114:188-192. doi: 10.1016/j.ypmed.2018.07.005. Epub 2018 Jul 5.

PMID:
29981791
26.

Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?

Silkensen SL, Schiffman M, Sahasrabuddhe V, Flanigan JS.

Glob Health Sci Pract. 2018 Jun 29;6(2):242-246. doi: 10.9745/GHSP-D-18-00206. Print 2018 Jun 27. No abstract available.

27.

Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.

Lou H, Gharzouzi E, Guerra SP, Domgue JF, Sawitzke J, Villagran G, Garland L, Boland JF, Wagner S, Rosas H, Troxler J, McMillen H, Kessing B, Alvirez E, Castillo M, Morales H, Argueta V, Rosingh A, van Aerde-van Nunen FJHB, Lopez G, Pinedo HM, Schiffman M, Dean M, Orozco R.

BMC Cancer. 2018 May 15;18(1):562. doi: 10.1186/s12885-018-4438-y.

28.

Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials.

Safaeian M, Castellsagué X, Hildesheim A, Wacholder S, Schiffman MH, Bozonnat MC, Baril L, Rosillon D; Costa Rica HPV Vaccine Trial and the PATRICIA study groups.

J Infect Dis. 2018 Jun 5;218(1):84-94. doi: 10.1093/infdis/jiy112.

29.

Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology.

Yu K, Hyun N, Fetterman B, Lorey T, Raine-Bennett TR, Zhang H, Stamps RE, Poitras NE, Wheeler W, Befano B, Gage JC, Castle PE, Wentzensen N, Schiffman M.

J Natl Cancer Inst. 2018 Nov 1;110(11):1222-1228. doi: 10.1093/jnci/djy044.

30.

Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy.

Demarco M, Cheung LC, Kinney WK, Wentzensen N, Lorey TS, Fetterman B, Poitras NE, Befano B, Castle PE, Schiffman M.

J Low Genit Tract Dis. 2018 Apr;22(2):97-103. doi: 10.1097/LGT.0000000000000382.

31.

An Introduction to the New Journal Forum.

Perkins RB, Schiffman M, Foster DC.

J Low Genit Tract Dis. 2018 Apr;22(2):89-90. doi: 10.1097/LGT.0000000000000369. No abstract available.

PMID:
29570562
32.

Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.

Demarco M, Carter-Pokras O, Hyun N, Castle PE, He X, Dallal CM, Chen J, Gage JC, Befano B, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Wentzensen N, Schiffman M.

J Clin Microbiol. 2018 Apr 25;56(5). pii: e01910-17. doi: 10.1128/JCM.01910-17. Print 2018 May.

33.

A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.

Wentzensen N, Walker J, Smith K, Gold MA, Zuna R, Massad LS, Liu A, Silver MI, Dunn ST, Schiffman M.

Am J Obstet Gynecol. 2018 Jun;218(6):604.e1-604.e8. doi: 10.1016/j.ajog.2018.02.009. Epub 2018 Feb 17.

PMID:
29462629
34.
35.

The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis.

Mirabello L, Clarke MA, Nelson CW, Dean M, Wentzensen N, Yeager M, Cullen M, Boland JF; NCI HPV Workshop, Schiffman M, Burk RD.

Viruses. 2018 Feb 13;10(2). pii: E80. doi: 10.3390/v10020080.

36.

Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 Years.

Silver MI, Gage JC, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Katki HA, Locke A, Kinney WK, Castle PE.

Cancer Prev Res (Phila). 2018 Mar;11(3):165-170. doi: 10.1158/1940-6207.CAPR-17-0293. Epub 2018 Feb 5.

37.

Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.

Clarke MA, Gradissimo A, Schiffman M, Lam J, Sollecito CC, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Castle PE, Wentzensen N, Burk RD.

Clin Cancer Res. 2018 May 1;24(9):2194-2202. doi: 10.1158/1078-0432.CCR-17-3251. Epub 2018 Feb 2.

38.

T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study.

Lang Kuhs KA, Lin SW, Hua X, Schiffman M, Burk RD, Rodriguez AC, Herrero R, Abnet CC, Freedman ND, Pinto LA, Hamm D, Robins H, Hildesheim A, Shi J, Safaeian M.

PLoS One. 2018 Jan 31;13(1):e0178167. doi: 10.1371/journal.pone.0178167. eCollection 2018.

39.

Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.

Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, Pinto LA, Hildesheim A, Gonzalez P; Costa Rica HPV Vaccine Trial (CVT) Group.

Vaccine. 2018 Aug 6;36(32 Pt A):4774-4782. doi: 10.1016/j.vaccine.2017.12.078. Epub 2018 Feb 1.

40.

Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.

Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, Befano B, Demarco M, Schussler J, Kinney WK, Raine-Bennett TR, Lorey TS, Poitras NE, Castle PE, Schiffman M.

J Clin Oncol. 2018 Apr 20;36(12):1184-1191. doi: 10.1200/JCO.2017.75.3442. Epub 2018 Jan 22.

41.

Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).

Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, Burk RD.

Virology. 2018 Mar;516:86-101. doi: 10.1016/j.virol.2018.01.002. Epub 2018 Jan 11.

42.

Accelerating cervical cancer control and prevention.

Wentzensen N, Schiffman M.

Lancet Public Health. 2018 Jan;3(1):e6-e7. doi: 10.1016/S2468-2667(17)30242-6. Epub 2017 Dec 19. No abstract available.

43.

Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting.

Rendle KA, Schiffman M, Cheung LC, Kinney WK, Fetterman B, Poitras NE, Lorey T, Castle PE.

Prev Med. 2018 Apr;109:44-50. doi: 10.1016/j.ypmed.2017.12.023. Epub 2017 Dec 27.

PMID:
29288782
44.

Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.

Sailer V, Schiffman MH, Kossai M, Cyrta J, Beg S, Sullivan B, Pua BB, Lee KS, Talenfeld AD, Nanus DM, Tagawa ST, Robinson BD, Rao RA, Pauli C, Bareja R, Beltran LS, Sigaras A, Eng KW, Elemento O, Sboner A, Rubin MA, Beltran H, Mosquera JM.

Cancer. 2018 Mar 1;124(5):1008-1015. doi: 10.1002/cncr.31173. Epub 2017 Dec 19.

45.

Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.

Landy R, Cheung LC, Schiffman M, Gage JC, Hyun N, Wentzensen N, Kinney WK, Castle PE, Fetterman B, Poitras NE, Lorey T, Sasieni PD, Katki HA.

Prev Med. 2018 Jun;111:429-435. doi: 10.1016/j.ypmed.2017.12.004. Epub 2017 Dec 6.

46.

Transarterial Embolization of a Bartholin Cyst before Resection.

Cornman-Homonoff J, Pereira N, Fenster TB, Schiffman MH.

J Minim Invasive Gynecol. 2018 Sep - Oct;25(6):938-940. doi: 10.1016/j.jmig.2017.11.016. Epub 2017 Nov 28. No abstract available.

PMID:
29195798
47.

Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.

Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Katki HA, Schiffman M.

Ann Intern Med. 2018 Jan 2;168(1):20-29. doi: 10.7326/M17-1609. Epub 2017 Nov 28.

PMID:
29181509
48.

Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.

Schiffman M, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Castle PE.

J Natl Cancer Inst. 2018 May 1;110(5):501-508. doi: 10.1093/jnci/djx225.

49.

Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.

Liu AH, Walker J, Gage JC, Gold MA, Zuna R, Dunn ST, Schiffman M, Wentzensen N.

Obstet Gynecol. 2017 Dec;130(6):1218-1225. doi: 10.1097/AOG.0000000000002330.

50.

Smoking and subsequent human papillomavirus infection: a mediation analysis.

Eldridge RC, Pawlita M, Wilson L, Castle PE, Waterboer T, Gravitt PE, Schiffman M, Wentzensen N.

Ann Epidemiol. 2017 Nov;27(11):724-730.e1. doi: 10.1016/j.annepidem.2017.10.004. Epub 2017 Oct 17.

Supplemental Content

Loading ...
Support Center